サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：血液ガス・電解質分析装置の世界市場 - 2023年～2030年
市場調査レポート
商品コード
1374824

血液ガス・電解質分析装置の世界市場 - 2023年～2030年

Global Blood Gas and Electrolyte Analyzers Market -2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 186 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血液ガス・電解質分析装置の世界市場 - 2023年～2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 186 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

血液ガス分析装置は注射器から血液を吸引し、pHと酸素分圧、二酸化炭素分圧を測定します。重炭酸濃度も計算されます。これらの結果は通常5分以内に解釈できます。

電解質分析装置は、生体試料（通常は血液または血清）中の電解質濃度を測定するために設計された特殊な医療機器です。電解質とは、ナトリウム（Na+）、カリウム（K+）、塩化物（Cl-）、重炭酸塩（HCO3-）、カルシウム（Ca2+）などの必須イオンのことで、人体内の様々な生理学的プロセスにおいて重要な役割を果たしています。これらの電解質レベルの正確な測定は、様々な病状の診断と管理に不可欠です。

市場促進要因：市場抑制要因

技術進歩の台頭

救急医療や救命医療の現場では、患者の生理学的状態が急速に変化することが重要な要因であり、急速に悪化する可能性があるため、患者の転帰を改善するために迅速な診断と臨床判断が必要となります。ポイント・オブ・ケア検査（POCT）は、分散化された患者中心のヘルスケアを提供するために設計された、クリティカルケア環境における重要な進歩です。血液測定、特に血液ガスや電解質への迅速なアクセスは、臨床転帰の改善につながります。

例えば、2023年6月、B&E Biotechnology Co.Ltd.（中国・煙台）のi-Checkハンドヘルド血液ガス電解質分析装置は、マイクロ流体技術と電気化学検出技術を採用しています。そのシングルユースカートリッジには、プラスチック基板、マルチバイオセンサーアレイ、キャリブレーターパウチ、サンプル注入ポート、廃液室が含まれます。特筆すべきは、マルチバイオセンサーアレイがシルクスクリーン印刷によって製造されていることです。使用される印刷インク材料は、貴金属を一切使用せず、炭素、銀、絶縁体のみから構成されており、他のメーカーに比べて製造コストを大幅に下げることができます。

さらに、がんや糖尿病などの慢性疾患治療のためのヘルスケア支出の増加が、予測期間中の市場成長を促進すると予想されています。この増加は、重症治療室や救急部における患者数の増加を示しており、血液ガス・電解質分析のニーズの高まりにつながっています。関係機関や政府は、患者に定期的な診断検査を受けるよう奨励することで、ヘルスケア支出を削減するプログラムに絶えず取り組んでいます。

市場力学：市場抑制要因

古典的な血液ガス分析では動脈血サンプルを必要とするため、サンプル採取時に多くの課題が生じる。例えば、サンプルに外気が混入するのを避けるため、特殊なタイトガスシリンジが使用されます。さらに、血液サンプルは採取後すぐに適切に混合されなければならず、そうでなければ沈殿が生じ、不均一なサンプルとなります。

また、市場の主な阻害要因としては、熟練した専門家の不足、分析装置のコスト、償還の問題、複雑な規制などが挙げられます。

このレポートの詳細- サンプル請求

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • テクノロジーの進歩
      • 慢性疾患の増加
    • 抑制要因
      • サンプル採取に伴う課題
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • 血液ガス分析装置
  • 電解質分析装置
  • 複合分析装置
  • その他

第8章 モダリティ別

  • 卓上型
  • ポータブル

第9章 エンドユーザー別

  • 病院
  • 中央検査室
  • ポイントオブケア
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Abbott Point of Care Inc
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Siemens Healthcare Private Limited
  • Cornley Hi-tech Co., LTD
  • Radiometer Medical ApS
  • Chengdu Seamaty Technology Co., Ltd
  • EDAN Instruments, Inc
  • ERBA Diagnostics Mannheim GmbH
  • F Hoffman La Roche Ltd
  • Medica Corporation
  • i-SENS, Inc

第13章 付録

目次
Product Code: MD7248

Overview

Blood gas analyzers aspirate blood from the syringe and measure pH and the partial pressures of oxygen and carbon dioxide. The bicarbonate concentration is also calculated. These results are usually available for interpretation within five minutes.

An electrolyte analyzer is a specialized medical device designed to measure the concentration of electrolytes in a biological sample, typically blood or serum. Electrolytes are essential ions, including sodium (Na + ), potassium (K + ), chloride (Cl-), bicarbonate (HCO3-), and calcium (Ca2 + ), that play crucial roles in various physiological processes within the human body. The accurate measurement of these electrolyte levels is vital for diagnosing and managing a wide range of medical conditions.

Market Dynamics: Drivers and Restraints

Rise in technological advancements

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centred healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes.

For instance, in June 2023, i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopted microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers.

Furthermore, increasing healthcare expenditure for the treatment of chronic diseases, such as cancer and diabetes, is expected to drive market growth over the forecast period. This increase indicates a rise in the number of patients in critical care units and emergency departments, which has led to the growing need for blood gas and electrolyte analysis. Pertinent organizations and governments are constantly engaging in programs to reduce healthcare expenditure by encouraging patients to undergo regular diagnostic examinations.

Market Dynamics: Restraint

Since classical blood gas analysis requires an arterial blood sample, many challenges arise during sample collection. For example, special gas-tight syringes are used to avoid adulteration of the sample with outside air. Furthermore, the blood sample must be properly mixed immediately after collection, otherwise, sedimentation will occur, resulting in an inhomogeneous sample.

Also, some of the major restraining factors in the market include the lack of skilled professionals, the cost of the analyzer, reimbursement issues, and complicated regulations.

For more details on this report - Request for Sample

Segment Analysis

The global blood gas and electrolyte analyzers is segmented based on product type, modality, end-user and region.

The blood gas analyzers from the product type segment accounted for approximately 41.2% of the market share

The blood gas analyzers from the product type segment accounted for 41.2% and it is expected to be dominated during the forecast period. Blood gas analyzers are used to measure combinations of pH, blood gas (i.e. pCO2 and pO2), electrolytes, and metabolite parameters from whole blood samples. Blood conservation is an important initiative in every clinical diagnostic lab or critical care facility. Therefore, a highly accurate blood gas analyzer can streamline work processes and reduce errors with minimum maintenance.

For instance, in June 2022, Sysmex America Inc., a leading name in the diagnostics solutions marketplace, received FDA clearance for the addition of a new feature to its N-10 Automated Hematology Analyzer with Blood Bank mode. This is the first automated analyzer to be cleared for residual WBC counting.

Moreover, in April 2021, Siemens Healthiness launched the epoc blood analysis system, It is a handheld, wireless solution with complete blood gas, a basic metabolic panel, and hematocrit and lactate on a single room temperature-stable test card, delivering patient-side results in less than 1 minute. It aids in supporting COVID-19 response efforts, where blood gas testing plays a critical role in managing infected patients.

Geographical Analysis

North America accounted for approximately 38.4% of the market share in 2022

North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the large presence of domestic and international medical device companies from both the developed and emerging markets boost the demand and growth of analyzes in the country. The region is expected to witness high demand for products such as arterial blood gas machines, electrolyte analyzer machines, and blood oxygen analyzers.

For instance, in March 2020, Siemens Healthineers stated that it won FDA clearance for its RapidPoint 500e blood gas analyzer for diagnosing and monitoring people in the intensive care unit, operating room or emergency room.

RapidPoint 500e is designed to generate blood gas, electrolyte, metabolite, CO-oximetry and neonatal bilirubin results that are then used to diagnose and monitor critically ill patients. The analyzer can be used in COVID-19 response efforts, where blood gas testing helps in managing infected patients and monitoring their respiratory distress.

COVID-19 Impact Analysis

The COVID-19 pandemic positively impacted the blood gas and electrolyte analyzers market. As amid the pandemic several surgeries were postponed, and non-emergency hospitalizations were cancelled impacted the market moderately.

However, there was a rise in the hospitalization rate of people suffering from COVID-19. Surging cases of the COVID-19 pandemic have increased demand for blood gas and electrolyte analyzers in hospitals, clinics, point of care centers will positively influence the industry growth.

Competitive Landscape

The major global players in the blood gas and electrolyte analyzers market include: Abbott Point of Care Inc., Siemens Healthcare Private Limited, Cornley Hi-tech Co., LTD, Radiometer Medical ApS, Chengdu Seamaty Technology Co., Ltd, EDAN Instruments, Inc., ERBA Diagnostics Mannheim GmbH, F Hoffman La Roche Ltd, Medica Corporation, i-SENS, Inc and among others.

Key Developments

  • In September 2021, Sensa Core Medical Instrumentation stated that the availability of its flagship Blood Gas Analyzer ST-200CC blood gas analyzers - Ultra Smart for hospitals, clinics and diagnostics centres through its network in India.
  • In May 2020, Roche stated the CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm.
  • In January 2020, Siemens Healthineers stated that its latest critical care testing solution, the RAPIDPoint 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration. The analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to diagnose and monitor critically ill patients in the intensive care unit, operating room, or emergency room.

Why Purchase the Report?

  • To visualize the global blood gas and electrolyte analyzers market segmentation-based product type, modality, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development
  • Excel data sheet with numerous data points of blood gas and electrolyte analyzers market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global blood gas and electrolyte analyzers market report would provide approximately 69 tables, 70 figures, and 185 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Modality
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Rise in the technology advancements
      • 4.1.1.2. Rise in prevalence of chronic diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Challenges associated with sample collection
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Blood Gas Analyzer*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Electrolyte Analyzer
  • 7.4. Combined Analyzer
  • 7.5. Others

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Benchtop*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Portable

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Centralized Laboratories
  • 9.4. Point of Care
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Abbott Point of Care Inc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Siemens Healthcare Private Limited
  • 12.3. Cornley Hi-tech Co., LTD
  • 12.4. Radiometer Medical ApS
  • 12.5. Chengdu Seamaty Technology Co., Ltd
  • 12.6. EDAN Instruments, Inc
  • 12.7. ERBA Diagnostics Mannheim GmbH
  • 12.8. F Hoffman La Roche Ltd
  • 12.9. Medica Corporation
  • 12.10. i-SENS, Inc

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us